Literature DB >> 7542000

DNA tetraploidy in Feulgen-stained bladder washings assessed by image cytometry.

M J Kline1, E J Wilkinson, R Askeland, R W Given, C Stephen, J B Hendricks.   

Abstract

The prognostic utility of DNA cytometry has been demonstrated for irrigation specimens from bladder neoplasms. While the traditional method of measuring the DNA content of cells recovered by bladder irrigation is flow cytometry, image analysis has been applied increasingly, with successful results. In some cases, image analysis has been shown to detect DNA aneuploid populations missed by flow cytometry. The DNA aneuploid population most frequently missed by flow cytometry is in the DNA tetraploid range. The purpose of the present study was to review image cytometry data on bladder washings analyzed at the University of Florida Diagnostic Referral Laboratories during a one-year period, with special emphasis on the subset with DNA tetraploid histograms. Of the 205 cases reviewed, 127 (62%) were DNA diploid, 36 (18%) DNA aneuploid and 42 (20%) DNA tetraploid. Corresponding cytology was negative in 113/127 (89%) of DNA diploid, 3/36 (8%) of DNA aneuploid and 29/42 (69%) of DNA tetraploid cases. Within the DNA tetraploid group, 45% of cases had no clinical (cystoscopic) or pathologic (cytologic and histologic) evidence of neoplasia. None of these patients developed tumors during follow-up. The presence of DNA tetraploidy in cytologically negative cases should be interpreted cautiously.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542000

Source DB:  PubMed          Journal:  Anal Quant Cytol Histol        ISSN: 0884-6812            Impact factor:   0.302


  2 in total

Review 1.  [Cytology of the urinary tract: Between uncertainty and clarity].

Authors:  L Bubendorf; P Dalquen; S Savic
Journal:  Pathologe       Date:  2009-12       Impact factor: 1.011

2.  Interstitial cystitis antiproliferative factor (APF) as a cell-cycle modulator.

Authors:  Hani H Rashid; Jay E Reeder; Mary J O'Connell; Chen-Ou Zhang; Edward M Messing; Susan K Keay
Journal:  BMC Urol       Date:  2004-04-06       Impact factor: 2.264

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.